Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples.
Fangyan YuFarzana AhmedStavroula SmilkouSayeda Yasmin-KarimFarzaneh DarbeheshtiAthina MarkouMartyn BullockIoannis BoukovinasViktor A AdalsteinssonEvi LianidouG Mike MakrigiorgosPublished in: Clinical chemistry (2024)
PD-UVME mutation/methylation enrichment performed prior to ddPCR magnifies low-level mutations or epigenetic changes and increases sensitivity and confidence in the results. It can assist with clinical decisions that hinge on the presence of trace alterations like BRAF V600E.